LDA analysis for Study ST003430

(Analysis AN005633 )

Select 3 or more experimental factors for PCA analysis.
GroupExperimental factor
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:10 nM GSK214069
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:200 nM GSK214069
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:500 nM GSK214069
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:50 nM GSK214069
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:Control
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:10 nM GSK214069
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:200 nM GSK214069
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:500 nM GSK214069
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:50 nM GSK214069
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:Control
Sample source:NA | Sample Type:Blank | Drug Treatment:NA
Sample source:NA | Sample Type:NA | Drug Treatment:NA
Sample source:NA | Sample Type:QC | Drug Treatment:NA

OR

Perform LDA on individual factors (all analyses in study)
  logo